Brits who puff on blue inhalers to open their airways and ease their breathing have been urged to reconsider their 'asthma ...

When it comes to treating conditions like asthma, pills or syrups are not better than inhalers. This is because these ...

On World Asthma Day 2026, experts are urging people to ditch misconceptions about inhalers, which remain the most effective treatment for asthma and COPD. Many still wrongly believe inhalers are habit ...

Millions of people with asthma use the blue inhaler to help relieve the symptoms when they have an attack but a doctor is now ...

The Strictly judge and her mum on Shirley’s love of dance, being a single-parent family, and the joy of living together now ...

Rothblatt connected those programs to longer-term scale, stating, "Each of the 2 products will exceed our total revenues of today, a revenue run rate of $3 billion going to $4 billion by the end of ...

United Therapeutics Corporation (NASDAQ: UTHR) Q1 2026 Earnings Call Transcript May 6, 2026 United Therapeutics Corporation ...

During a candidate forum in Sioux City, three Democrats competing for a chance to flip Iowa’s most conservative congressional ...

Pulmonary drug delivery has long been associated with a familiar set of indications, particularly asthma and chronic obstructive pulmonary disease (COPD). Those conditions remain central to the ...

AstraZeneca's IL-33-targeting antibody tozorakimab has hit the target in the third of three phase 3 trials in chronic obstructive pulmonary disease (COPD), making a clean sweep of results and setting ...

Q1 2026. Management View "Three full quarters into the commercial launch of YUTREPIA, I would summarize the state of our business with 3 ma ...

Forbes contributors publish independent expert analyses and insights. Transformative Travel: I look at how travel can change lives. Air travel is booming. But that has come with record-high passenger ...